Form 8-K - Current report:
SEC Accession No. 0001104659-22-046150
Filing Date
2022-04-15
Accepted
2022-04-14 19:40:12
Documents
12
Period of Report
2022-04-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2212735d1_8k.htm   iXBRL 8-K 24356
  Complete submission text file 0001104659-22-046150.txt   196437

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ntra-20220408.xsd EX-101.SCH 3027
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ntra-20220408_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ntra-20220408_pre.xml EX-101.PRE 22591
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2212735d1_8k_htm.xml XML 3605
Mailing Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753
Business Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753 650-249-9090
Natera, Inc. (Filer) CIK: 0001604821 (see all company filings)

EIN.: 010894487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37478 | Film No.: 22828703
SIC: 8071 Services-Medical Laboratories